Literature DB >> 2945258

Erythroderma: review of 82 cases.

L E King, R G Dufresne, G L Lovett, M A Rosin.   

Abstract

We reviewed 82 cases of erythroderma, including clinical, laboratory, and biopsy material. The diseases most commonly associated with erythroderma were drug eruptions (34%), preexisting dermatoses (30%), and lymphoreticular neoplasms (20%), especially cutaneous T cell lymphomas (CTCL). The prognosis was related to the associated process; all deaths occurred in the drug or lymphoma groups. The clinical presentation of erythroderma was fairly uniform, with malaise (34%), pruritus (36%), and a subjective chilly sensation (34%) the most common symptoms. Keratoderma of the palms and soles (37%), mild generalized adenopathy (26%), and hepatomegaly (9%) were also common. Splenomegaly was rare (1%). Skin biopsy revealed the cause in 43% of the patients, but lymph node biopsy was not generally helpful in the initial evaluation. Although numerous laboratory values were abnormal, most findings were nondiagnostic and were related to the inflammatory process. A major exception was the Sezary cell preparation, which was selective for CTCL. A previously undiagnosed chronic erythroderma in a patient with no underlying skin disease may be the initial manifestation of CTCL. Thus, repeated evaluations and close follow-up are recommended.

Entities:  

Mesh:

Year:  1986        PMID: 2945258     DOI: 10.1097/00007611-198610000-00005

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  6 in total

1.  Paraneoplastic erythroderma: unusual presentation secondary to diffuse large B cell lymphoma.

Authors:  Puo Nen Lim; Christopher P Fox; Manjula Pammi; Anand Patel
Journal:  BMJ Case Rep       Date:  2019-05-30

2.  Primary papillary hyperplasia of the gallbladder mimicking gallbladder cancer.

Authors:  Hiroyuki Baba; Mai Wakabayashi; Atsushi Oba; Takashi Tsubomoto; Hiroshi Nakamura; Takahiro Sanada; Hiroshi Kuwabara; Kazumi Nakajima; Narihide Goseki
Journal:  Int Surg       Date:  2014 May-Jun

3.  Erythroderma: a clinical study of 97 cases.

Authors:  Maryam Akhyani; Zahra S Ghodsi; Siavash Toosi; Hossein Dabbaghian
Journal:  BMC Dermatol       Date:  2005-05-09

4.  Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL).

Authors:  Madeleine Duvic; Rakshandra Talpur; Xiao Ni; Chunlei Zhang; Parul Hazarika; Cecilia Kelly; Judy H Chiao; John F Reilly; Justin L Ricker; Victoria M Richon; Stanley R Frankel
Journal:  Blood       Date:  2006-09-07       Impact factor: 22.113

5.  Erythroderma: a prospective study of 309 patients followed for 12 years in a tertiary center.

Authors:  Denis Miyashiro; José Antonio Sanches
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.379

6.  A Study of Correlation Between Clinical and Histopathological Findings of Erythroderma in North Bengal Population.

Authors:  Sabyasachi Banerjee; Swarup Ghosh; Rajesh Kumar Mandal
Journal:  Indian J Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.